• Optimism wRosie 2 copy

     

     

    JOIN OUR COMMUNITY OF SUPPORTERS

     

  • imgSlide

    RUNNING FOR ANSWERS 5K 

    Register here for our 2015 event on October 18 in Philadelphia! View pictures from our 2014 event here .

    readMoreBlue

     

  • finalNIH

     

     

     

    DTRF VISITS NIH

    DTRF at NIH in DC with researchers running a clinical trial on desmoid tumors.

     

  • PLAN A DTRF FUNDRAISER final

     

     

     

    PLAN A DTRF FUNDRAISER

    Create your fundraising page here.

     

     

     

     

 
inTheSpotlightTitle
  •  

                   PM date announcement

    Join us on 10/17 for our Patient Meeting in Philly, getting you ready for Running for Answers 5K on 10/18! Register here, and get all the info you need from lodging to fundraising support!

  •                    

                          NCI 2

     

    NCI currently has 2 important clinical trials for the treatment of desmoid tumors.

    Learn more about the phase II trial on Gamma-Secretase Inhibitor PF-0308401, with treatments at NCI in Bethesda, here.

    Visit here for more information about the phase III trial on sorafenib/ nexavar, which will be administered at institutions across the U.S.

  •  

                               11695857 799304283517901 1354084025245765496 n

     

    On Friday, DTRF co-founders Marlene Portnoy and Jeanne Whiting had a meeting with the FDA regarding Patient Reported Outcome in drug approval. More details to follow at the DTRF Patient Meeting on 10/17 in Philadelphia. Register today at www.runningforanswers.com.

     

newsTitle